Riskpilot← Back to searchSign inGet full accessUNEEG medical A/S
A/SActiveCVR 29140774Borupvang 2Research and experimental development on natural sciences and engineering · NACE 7210Est. 200534 employeeswww.uneeg.com
Revenue 2025
DKK -74,3M
+49% vs 2024
EBITDA margin
177.9%
-1% vs 2024
Equity ratio
-57.5%
Financial strength
Net profit 2025
DKK -224,4M
-102% vs 2024
| Revenue | DKK -74,3M | +49% |
| EBITDA | DKK -132,2M | -1% |
| Net profit | DKK -224,4M | -102% |
| Total assets | DKK 214,7M | -32% |
| Equity | DKK -123,5M | -223% |
| Employees | 34 | — |
Legal name
UNEEG medical A/S
CVR number
29140774
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7. oktober 2005
Share capital
DKK 5.454.786
Employees
34 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med et bestyrelsesmedlem; eller af et bestyrelsesmedlem i forening med en direktør eller af tre bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er udvikling og kommercialisering af elektromedicinsk
udstyr til monitorering, varsling, diagnosticering og behandling samt al
virksomhed, som efter bestyrelsens skøn er beslægtet hermed.
Address
Borupvang 2
Phone
+4540638000
Website
www.uneeg.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -30.325 | -45.136 | -52.379 | -49.863 | -74.287 |
| Staff expenses | -47.288 | -62.727 | -80.279 | -80.912 | -57.872 |
| EBITDA | -77.613 | -107.863 | -132.658 | -130.775 | -132.159 |
| Depreciation & amort. | -18.196 | -27.402 | -32.631 | -4.793 | -9.148 |
| EBIT | -95.809 | -135.265 | -165.289 | -135.568 | -141.307 |
| Net financials | -16.977 | -10.082 | -16.103 | -11.486 | -18.993 |
| Profit before tax | -112.786 | -145.347 | -181.392 | -147.054 | -160.300 |
| Tax | -24.184 | -33.781 | -40.714 | -35.951 | 64.110 |
| Net profit | -88.602 | -111.566 | -140.678 | -111.103 | -224.410 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 165.875 | 211.074 | 272.548 | 314.398 | 214.707 |
| Equity | 131.257 | 179.054 | 38.417 | 100.411 | -123.483 |
| Long-term debt | 7.804 | 8.101 | 200.304 | 192.864 | 313.851 |
| Short-term debt | 22.855 | 23.919 | 33.827 | 21.123 | 24.339 |
| Total debt | 30.659 | 32.020 | 234.131 | 213.987 | 338.190 |
EBITDA margin
-13215900000.0%
This company
15.8%
Market median
-83644936809% vs market
20212025
Equity ratio
-57.5%
This company
38.2%
Market median
-251% vs market
20212025
Return on equity
-22441000000.0%
This company
18.4%
Market median
-121961956622% vs market
20212025
Net profit margin
-22441000000.0%
This company
8.1%
Market median
-277049382816% vs market
20212025
Asset turnover
-0.35×
This company
1.12×
Market median
-131% vs market
20212025
Debt / equity
2.74×
This company
0.62×
Market median
-342% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MD Chief Executive Officer | Chief Executive Officer | 2025 |
HK | Deputy | 2025 |
| Former (2) | ||
TS Management | Management | 2018 – 2025 |
RS Management | Management | 2005 – 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Chairman | 2012 | |
| Board of Directors | 2009 | |
| Board of Directors | 2025 | |
| Board of Directors | 2019 | |
| Board of Directors | 2025 | |
| Former (5) | ||
| Board of Directors | 2019 – 2025 | |
| Board of Directors | 2010 – 2014 | |
| Board of Directors | 2005 – 2019 | |
| Board of Directors | 2005 – 2017 | |
| Board of Directors | 2018 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 90–99.99% | 90–99.99% | 2021 | |
| Company | 15–19.99% | 15–19.99% | 2012 | |
| Company | 10–14.99% | 10–14.99% | 2008 | |
| Company | 50–66.65% | 50–66.65% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
T&W Medical A/S
UNEEG medical A/S Board members of UNEEG medical A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Dal Stenfeldt | Chief Executive Officer | 0 companies |
| Torben Sandgren | Management | 0 companies |
| Henning Kirketerp Beck-Nielsen | Deputy | 0 companies |
| Rasmus Stig Jensen | Management | 0 companies |
| Peter Willems-Alnøe | Board of Directors | 0 companies |
| Julian Tøpholm | Board of Directors | 0 companies |
| Søren Erik Westermann | Chairman | 0 companies |
| Kurt Christiansen | Board of Directors | 0 companies |
| Richard Tøpholm | Board of Directors | 0 companies |
| Henrik Skak Bender | Board of Directors | 0 companies |
| Lars Nørgaard | Board of Directors | 0 companies |
| Claus Henrik Christiansen | Board of Directors | 0 companies |
| Philip Just Larsen | Board of Directors | 0 companies |
| Andreas Brock Midtgaard | Board of Directors | 0 companies |